CONy 2020 ALS Program

*This program is subject to change

Saturday, March 28, 2020

ALS should not be considered a neuromuscular disorder

Host: Giancarlo Logroscino, Italy
Yes: Michael van Es, The Netherlands
No: Monica Povedano Panades, Spain

Patients should set the agenda for therapeutic trials in ALS

Host: Albert Ludolph, Germany
Yes: Paul Wicks, USA

The study of mice has been detrimental to developing therapy for ALS

Host: Kevin Talbot, UK
Yes: Peter Bede, Ireland
No: Elizabeth Fisher, UK